A detailed history of Lpl Financial LLC transactions in Repligen Corp stock. As of the latest transaction made, Lpl Financial LLC holds 21,842 shares of RGEN stock, worth $3.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,842
Previous 16,828 29.8%
Holding current value
$3.11 Million
Previous $2.12 Million 53.23%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$119.79 - $167.35 $600,627 - $839,092
5,014 Added 29.8%
21,842 $3.25 Million
Q2 2024

Aug 07, 2024

SELL
$120.0 - $182.95 $67,200 - $102,452
-560 Reduced 3.22%
16,828 $2.12 Million
Q1 2024

May 10, 2024

SELL
$170.78 - $208.42 $15,370 - $18,757
-90 Reduced 0.51%
17,388 $3.2 Million
Q4 2023

Feb 14, 2024

SELL
$114.17 - $185.35 $6,850 - $11,121
-60 Reduced 0.34%
17,478 $3.14 Million
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $36,360 - $46,245
-262 Reduced 1.47%
17,538 $2.79 Million
Q2 2023

Jul 31, 2023

BUY
$138.42 - $180.31 $260,091 - $338,802
1,879 Added 11.8%
17,800 $2.52 Million
Q1 2023

May 10, 2023

BUY
$154.26 - $198.1 $271,806 - $349,052
1,762 Added 12.44%
15,921 $2.68 Million
Q4 2022

Feb 07, 2023

SELL
$162.42 - $220.56 $12,993 - $17,644
-80 Reduced 0.56%
14,159 $2.4 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $71,386 - $114,013
-445 Reduced 3.03%
14,239 $2.66 Million
Q2 2022

Aug 12, 2022

BUY
$140.68 - $188.02 $623,212 - $832,928
4,430 Added 43.2%
14,684 $2.41 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $340,433 - $544,811
-2,112 Reduced 17.08%
10,254 $1.93 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $87,399 - $107,477
-353 Reduced 2.78%
12,366 $3.28 Million
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $267,613 - $445,464
1,374 Added 12.11%
12,719 $3.68 Million
Q2 2021

Aug 13, 2021

SELL
$165.87 - $220.95 $196,555 - $261,825
-1,185 Reduced 9.46%
11,345 $2.27 Million
Q1 2021

May 14, 2021

BUY
$180.37 - $226.26 $198,948 - $249,564
1,103 Added 9.65%
12,530 $2.44 Million
Q4 2020

Feb 12, 2021

BUY
$148.08 - $206.57 $637,780 - $889,696
4,307 Added 60.49%
11,427 $2.19 Million
Q3 2020

Nov 09, 2020

BUY
$122.51 - $158.27 $147,624 - $190,715
1,205 Added 20.37%
7,120 $1.05 Million
Q2 2020

Aug 13, 2020

BUY
$94.33 - $140.48 $145,834 - $217,182
1,546 Added 35.39%
5,915 $731,000
Q1 2020

May 14, 2020

SELL
$84.96 - $109.14 $154,287 - $198,198
-1,816 Reduced 29.36%
4,369 $422,000
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $8,270 - $10,424
-112 Reduced 1.78%
6,185 $572,000
Q3 2019

Nov 13, 2019

BUY
$76.65 - $95.51 $152,916 - $190,542
1,995 Added 46.37%
6,297 $483,000
Q2 2019

Aug 09, 2019

BUY
$54.2 - $85.95 $233,168 - $369,756
4,302 New
4,302 $370,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.